{
  "content_hash": "19fa15f281558094d33953f31db68bcdd1f40dfe2ee5eb591bbd6c584e207b2c",
  "share_id": "wsdxex",
  "title": "What we still don’t know about weight-loss drugs",
  "optimized_headline": "New Insights: Unanswered Questions About Weight-Loss Drugs Revealed",
  "url": "https://www.technologyreview.com/2025/11/28/1128511/what-we-still-dont-know-about-weight-loss-drugs/",
  "source": "MIT Technology Review",
  "published_at": "2025-11-28T10:00:00.000Z",
  "raw_excerpt": "MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next. You can read more from the series here. Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound, became the first healthcare…",
  "raw_body": "MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next. You can read more from the series here. Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound, became the first healthcare…",
  "category": "trends_risks_outlook",
  "category_confidence": "medium",
  "speedrun": "Weight-loss drugs like Eli Lilly's Mounjaro and Zepbound are gaining attention as they enter the healthcare spotlight. Despite their potential, many uncertainties remain about their long-term effects and overall effectiveness. Recent discussions emphasize the need for more research to understand how these medications work and their implications for patients. This is crucial now as obesity rates continue to rise and more people seek effective solutions.",
  "why_it_matters": [
    "Patients considering these drugs need clarity on their long-term safety and efficacy, which is still uncertain.",
    "The growing interest in weight-loss medications indicates a shift in healthcare towards treating obesity more aggressively, reflecting changing attitudes about weight management."
  ],
  "lenses": {
    "eli12": "Weight-loss drugs are becoming popular, but we still have many questions about how safe and effective they are over time. Think of it like trying a new diet; it might work for some, but we need to know if it’s healthy in the long run. For everyday people, understanding these drugs can help them make informed choices about managing their weight.",
    "pm": "For product managers and founders, the rise of weight-loss drugs indicates a growing user need for effective obesity treatments. This could lead to opportunities for new products that enhance or complement these medications. However, understanding the cost and efficiency of these drugs will be crucial for market positioning.",
    "engineer": "From a technical perspective, weight-loss drugs like Mounjaro and Zepbound operate by targeting specific pathways in the body to regulate appetite and metabolism. However, the lack of long-term data on their effectiveness and safety raises important questions about their use. Developers should focus on gathering comprehensive clinical data to address these uncertainties."
  },
  "hype_meter": 2,
  "model_meta": {
    "model": "gpt-4o-mini",
    "prompt_version": "v2.1"
  },
  "created_at": "2025-11-29T03:54:26.964Z",
  "updated_at": "2025-11-29T03:54:26.964Z",
  "processing_order": 1764388466965
}